PDB57 REAL-WORLD ECONOMIC OUTCOMES AMONG PATIENTS WITH TYPE 2 DIABETES (T2D) TREATED WITH DULAGLUTIDE (DU) VS. BASAL INSULIN (BI) IN THE US: THE DISPELTM STUDY
Abstract
Authors
R. Mody Q. Huang M. Yu X. Zhang L. Wang M. Grabner H. Patel